drug protocol number

H23-107

drug sponsor

Abbvie

drug study

Upadacitinib (Rinvoq)

drug trial site

King Faisal General Hospital (Makkah), Mohammed Dossary Hospital - Al Khobar, King Fahad Central Hospital (Jazan), East Jeddah General Hospital, Hira Hospital (Makkah) , Aseer Central Hospital (Abha)

drug status

Ongoing

drug phase